XML 49 R33.htm IDEA: XBRL DOCUMENT v3.22.4

Revenues (Tables)

12 Months Ended

Dec. 31, 2022

Revenues [Abstract]

Schedule of net product revenues by product

The Company’s net product revenues consisted of the following for the years ended December 31:

						2022						2021
Products:
Kristalose						$	15,205,155					$	15,993,658
Sancuso						13,205,603						—
Vibativ						7,487,462						11,704,062
Caldolor						4,827,200						4,970,301
Acetadote						501,040						850,993
Omeclamox-Pak						29,145						(388,657)
Vaprisol						(447,697)						1,859,581
RediTrex						(126,726)						55,321
Total net product revenues						$	40,681,182					$	35,045,259

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenuesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration